SEC Form 4 · accession 0001179110-17-014377
BeOne Medicines Ltd. · ONC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jane Huang
Officer — CMO, Hematology
Period of report
Nov 16, 2017
Accepted (ET)
Nov 20, 2017 · 5:14 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001651308
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| American Depositary SharesF1,F3 | Nov 16, 2017 | S | 600 | $85.00 | D | 2,100 | I | See Footnote |
| American Depositary SharesF1,F3 | Nov 20, 2017 | S | 1,000 | $87.00 | D | 1,100 | I | See Footnote |
| Ordinary Shares | holding | — | — | — | 264,900 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Each American Depositary Share represents 13 Ordinary Shares.
- F2The sale was effected pursuant to a Rule 10b5-1 trading plan adopted by The Jane Edna Huang Living Trust.
- F3These securities are held by The Jane Edna Huang Living Trust.